CATALOGO DEI PRODOTTI DELLA RICERCA

UGEL, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.492
NA - Nord America 5.102
AS - Asia 3.463
SA - Sud America 498
AF - Africa 127
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.971
RU - Federazione Russa 2.092
SG - Singapore 1.308
IT - Italia 942
CN - Cina 926
GB - Regno Unito 879
BR - Brasile 389
DE - Germania 370
VN - Vietnam 364
HK - Hong Kong 347
FI - Finlandia 229
FR - Francia 213
IE - Irlanda 206
SE - Svezia 202
KR - Corea 103
NL - Olanda 102
BD - Bangladesh 99
IN - India 66
CA - Canada 62
ID - Indonesia 52
UA - Ucraina 50
MX - Messico 42
JP - Giappone 39
TR - Turchia 39
AT - Austria 38
AR - Argentina 36
ZA - Sudafrica 33
ES - Italia 30
BE - Belgio 29
PL - Polonia 26
NG - Nigeria 24
IQ - Iraq 21
AU - Australia 20
CO - Colombia 20
TG - Togo 18
CZ - Repubblica Ceca 17
BJ - Benin 15
PK - Pakistan 14
SA - Arabia Saudita 14
EC - Ecuador 13
VE - Venezuela 12
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 10
CH - Svizzera 9
IL - Israele 9
JM - Giamaica 9
LT - Lituania 8
TN - Tunisia 8
PE - Perù 7
PT - Portogallo 7
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PS - Palestinian Territory 5
CY - Cipro 4
HR - Croazia 4
IR - Iran 4
OM - Oman 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GM - Gambi 1
Totale 14.692
Salva come PNG Salva come JPEG
Città #
Moscow 763
Ashburn 732
Southend 724
Singapore 650
San Jose 529
Verona 488
Chandler 408
Dallas 404
Hong Kong 333
Munich 207
New York 199
Dublin 198
Beijing 195
Jacksonville 187
Council Bluffs 177
Woodbridge 159
The Dalles 156
Ann Arbor 141
Los Angeles 125
Helsinki 107
Houston 98
Ho Chi Minh City 88
Redmond 84
Hanoi 63
Lawrence 61
Princeton 61
Jinan 58
Wilmington 58
Shenyang 51
Orem 49
Buffalo 48
Milan 48
Santa Clara 44
Nanjing 42
São Paulo 42
Jakarta 41
London 40
Redondo Beach 40
Turku 36
Dong Ket 34
Tokyo 34
Amsterdam 32
Denver 30
Brussels 29
Columbus 29
Chicago 28
Lappeenranta 28
Tianjin 28
Brooklyn 26
Frankfurt am Main 26
Johannesburg 26
Montreal 25
Zhengzhou 25
Atlanta 24
Abuja 23
Chennai 22
Hebei 22
Nanchang 21
Phoenix 21
Vienna 21
Washington 21
Mexico City 20
Ningbo 20
Warsaw 20
Haiphong 19
Hangzhou 19
Haikou 18
Lomé 18
Stockholm 18
Toronto 18
Guangzhou 17
Nuremberg 17
Redwood City 17
Sindelfingen 17
Rome 16
Changsha 15
Cotonou 15
Manchester 15
Paris 15
Seattle 15
Seoul 15
Boston 14
Da Nang 14
Jiaxing 14
Poplar 14
San Francisco 13
Boydton 12
Sydney 12
Ankara 11
Boardman 11
Madrid 11
Norwalk 11
Padova 11
Rio de Janeiro 11
Taiyuan 11
Baghdad 10
Bologna 10
Querétaro 10
Sant'Ambrogio di Valpolicella 10
Taizhou 10
Totale 9.073
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 312
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 303
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 295
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 286
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 282
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 254
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 254
Deciphering the state of immune silence in fatal COVID-19 patients 240
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 239
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 232
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 230
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 224
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 218
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 216
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 212
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 209
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 209
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 200
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 198
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 195
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 195
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 190
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 188
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 182
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 176
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 173
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 168
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 166
The Endless Saga of Monocyte Diversity 165
Anti-telomerase T cells adoptive transfer 165
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 165
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 163
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 163
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 159
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 159
Local ablation disrupts immune evasion in pancreatic cancer 158
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 157
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 157
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 156
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 156
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 155
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 152
The Engagement Between MDSCs and Metastases: Partners in Crime 147
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 146
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 142
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 142
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 141
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 140
Therapeutic targeting of myeloid-derived suppressor cells. 138
Role of arginine metabolism in immunity and immunopathology. 137
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 136
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 136
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 133
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 133
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells 133
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 132
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 132
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 130
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 130
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 130
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 129
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 129
T-cell tracking using Cerenkov and radioluminescence imaging 129
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 127
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 126
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 123
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells 123
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 119
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 119
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. 119
Immune-guided therapy of COVID-19. 119
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 118
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 114
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 112
Moonlighting Proteins Are Important Players in Cancer Immunology 110
Tumor-Induced Myeloid-Derived Suppressor Cells 109
The dark side of tumor-associated endothelial cells 107
Monocytes in the Tumor Microenvironment 100
HER2 Aberrations in NSCLC: So Close Yet So Far 98
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 96
GateMeClass: Gate Mining and Classification of cytometry data 95
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 94
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 86
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines 84
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells 83
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 81
Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer 74
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 71
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 43
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 38
Corneal regenerative contribution of endogenous and grafted limbal-corneal cells in a mouse model of simple limbal-corneal epithelial transplantation 28
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 10
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 5
Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders 3
Totale 14.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.645
article - articoli 45.795
book - libri 0
conference - conferenze 1.657
curatela - curatele 0
other - altro 1.672
patent - brevetti 0
selected - selezionate 0
volume - volumi 521
Totale 99.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 0 86
2021/2022553 38 152 37 21 18 12 17 38 49 17 41 113
2022/20231.268 72 165 105 221 102 310 23 71 130 8 38 23
2023/2024921 34 51 63 89 121 188 66 65 15 70 131 28
2024/20252.651 118 108 139 393 100 118 255 208 375 135 255 447
2025/20267.160 440 358 443 1.131 1.849 428 699 379 547 478 234 174
Totale 14.932